Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Engineered bacteria could help protect ‘good’ gut microbes from antibiotics

Engineered bacteria could help protect ‘good’...

COVID-19 surgical backlogs persist: 4 things for hospital leaders to know

COVID-19 surgical backlogs persist: 4 things for...

8 recent infection control study findings

8 recent infection control study findings...

Widely used hospital gowns show signs of exposing workers to infection

Widely used hospital gowns show signs of...

Researchers show how bending implantable medical devices can lead to bacterial growth

Researchers show how bending implantable medical...

Lessons learned in COVID-19: New guidance for antibiotic use in a pandemic

Lessons learned in COVID-19: New guidance for...

National Diabetes Foot Care Report

National Diabetes Foot Care Report The National...

Las bacterias terrestres pueden crecer en nutrientes del espacio

Science Daily informó recientemente sobre un...

Diabetic foot ulcers: “Just chop it off”?

Diabetic-foot-ulcers-Just-chop...